Does DEFLAZACORT Cause Nephrolithiasis? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Nephrolithiasis have been filed in association with DEFLAZACORT (Deflazacort Oral Suspension). This represents 0.8% of all adverse event reports for DEFLAZACORT.
32
Reports of Nephrolithiasis with DEFLAZACORT
0.8%
of all DEFLAZACORT reports
0
Deaths
11
Hospitalizations
How Dangerous Is Nephrolithiasis From DEFLAZACORT?
Of the 32 reports, 11 (34.4%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFLAZACORT. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does DEFLAZACORT Cause?
Weight increased (468)
Off label use (315)
Fall (206)
Vomiting (139)
Nasopharyngitis (134)
Abnormal behaviour (129)
Influenza (120)
Rash (114)
Headache (104)
Pyrexia (104)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which DEFLAZACORT Alternatives Have Lower Nephrolithiasis Risk?
DEFLAZACORT vs DEGARELIX
DEFLAZACORT vs DELAFLOXACIN MEGLUMINE
DEFLAZACORT vs DELAMANID
DEFLAZACORT vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEFLAZACORT vs DELAVIRDINE